Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bram Verstockt

Showing results (11-20 of 167) with videos related to

Pageof 17
Sort By:
Clinical & Translational Immunology|February 28, 2018
Genome-wide association studies in Crohn's disease: Past, present and futureBram Verstockt, Kenneth Gc Smith, James C Lee
Journal of Gastroenterology|March 21, 2018
New treatment options for inflammatory bowel diseasesBram Verstockt, Marc Ferrante, Séverine Vermeire, et al.
Scandinavian Journal of Gastroenterology|September 27, 2018
When IBD is not IBDBram Verstockt, Séverine Vermeire, Gert Van Assche, et al.
Expert Opinion on Biological Therapy|November 8, 2016
Biological therapy targeting the IL-23/IL-17 axis in inflammatory bowel diseaseBram Verstockt, Gert Van Assche, Séverine Vermeire, et al.
Journal of Crohn'S & Colitis|October 13, 2018
GlycA, a Nuclear Magnetic Resonance Spectroscopy Measure for Protein Glycosylation, is a Viable Biomarker for Disease Activity in IBDTim Dierckx, Bram Verstockt, Séverine Vermeire, et al.
Frontiers in Microbiology|May 28, 2021
Computational Biology and Machine Learning Approaches to Understand Mechanistic Microbiome-Host InteractionsPadhmanand Sudhakar, Kathleen Machiels, Bram Verstockt, et al.
Expert Review of Gastroenterology & Hepatology|January 7, 2023
Evaluating the potential of artificial intelligence in ulcerative colitisPieter Sinonquel, Alessandro Schilirò, Bram Verstockt, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 26, 2024
Calibration, Clinical Utility, and Specificity of Clinical Decision Support Tools in Inflammatory Bowel DiseaseDahham Alsoud, João Sabino, Marc Ferrante, et al.
The Lancet. Gastroenterology & Hepatology|December 11, 2019
Personalised medicine in Crohn's diseaseNurulamin M Noor, Bram Verstockt, Miles Parkes, et al.
Journal of Crohn'S & Colitis|March 19, 2025
Serum extracellular RNAs as a noninvasive approach to differentiate inflammatory bowel disease subtypes: a proof-of-concept studySare Verstockt, João Sabino, Marc Ferrante, et al.
Pageof 17

Showing results (11-20 of 167) with videos related to

Sort By:
Pageof 17
Clinical & Translational Immunology|February 28, 2018
Genome-wide association studies in Crohn's disease: Past, present and futureBram Verstockt, Kenneth Gc Smith, James C Lee
Journal of Gastroenterology|March 21, 2018
New treatment options for inflammatory bowel diseasesBram Verstockt, Marc Ferrante, Séverine Vermeire, et al.
Scandinavian Journal of Gastroenterology|September 27, 2018
When IBD is not IBDBram Verstockt, Séverine Vermeire, Gert Van Assche, et al.
Expert Opinion on Biological Therapy|November 8, 2016
Biological therapy targeting the IL-23/IL-17 axis in inflammatory bowel diseaseBram Verstockt, Gert Van Assche, Séverine Vermeire, et al.
Journal of Crohn'S & Colitis|October 13, 2018
GlycA, a Nuclear Magnetic Resonance Spectroscopy Measure for Protein Glycosylation, is a Viable Biomarker for Disease Activity in IBDTim Dierckx, Bram Verstockt, Séverine Vermeire, et al.
Frontiers in Microbiology|May 28, 2021
Computational Biology and Machine Learning Approaches to Understand Mechanistic Microbiome-Host InteractionsPadhmanand Sudhakar, Kathleen Machiels, Bram Verstockt, et al.
Expert Review of Gastroenterology & Hepatology|January 7, 2023
Evaluating the potential of artificial intelligence in ulcerative colitisPieter Sinonquel, Alessandro Schilirò, Bram Verstockt, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 26, 2024
Calibration, Clinical Utility, and Specificity of Clinical Decision Support Tools in Inflammatory Bowel DiseaseDahham Alsoud, João Sabino, Marc Ferrante, et al.
The Lancet. Gastroenterology & Hepatology|December 11, 2019
Personalised medicine in Crohn's diseaseNurulamin M Noor, Bram Verstockt, Miles Parkes, et al.
Journal of Crohn'S & Colitis|March 19, 2025
Serum extracellular RNAs as a noninvasive approach to differentiate inflammatory bowel disease subtypes: a proof-of-concept studySare Verstockt, João Sabino, Marc Ferrante, et al.
Pageof 17